Volume 13, Issue 2 (2023)                   JMBS 2023, 13(2): 178-201 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

mirmohamadi S, SOLTANI M, mahboudi F, shahbazi M. A look at the Factors Affecting the Commercialization of Products in Iranian Medical Biotechnology Accelerators. JMBS 2023; 13 (2) :178-201
URL: http://biot.modares.ac.ir/article-22-50560-en.html
1- TEHRAN UNIVERSITY
2- TEHRAN UNIVERSITY , mortezasoltanee@ut.ac.ir
3- Pasteur Institute
4- Tehran university
Abstract:   (721 Views)
This study investigates the factors affecting the commercialization of products in medical biotechnology accelerators, it also demonstrates the priority of these factors. The research is applied and descriptive survey. It has been done in two phases, qualitative and quantitative. Based on the general purpose of this study, to provide a framework for the commercialization of products in medical biotechnology accelerators, we interviewed with informed experts. 62 sub-codes were obtained as effective factors in the commercialization of products in medical biotechnology accelerators, which were classified into 5 main dimensions including individual, organizational, industry and competition, institutional and product. These dimensions are presented as a framework. In the quantitative phase, the main dimensions as well as the sub-themes were ranked in the main dimension. Finally, the priority of the main dimensions was as follows: 1. Individual (personality, behavioral and mental characteristics of the mentor and manager) 2. Industry and competition (interaction with pharmaceutical companies as customers, investors, etc.) 3. Organizational (experience of startup teams, codified strategy, R&D, etc.) 4. Product (value added and high-tech) 5. Institutional (government is pragmatic to the country's slogans, interaction with government managers, etc.).
Full-Text [PDF 550 kb]   (186 Downloads)    
Article Type: Original Research | Subject: Pharmaceutical Biotechnology
Received: 2021/02/28 | Accepted: 2022/03/6 | Published: 2023/07/10

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.